{"entity":{"type":"insider","cik":"0001428524","url":"/insider/0001428524","json_url":"/insider/0001428524.json","name":"Kessler Paul D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":9,"first":"2008-03-07","last":"2012-04-09","span_basis":"filed_date"},"name_variants":[{"name":"Kessler Paul D.","source":"filing","n_filings":9,"first_seen":"2008-03-07","last_seen":"2012-04-09"}],"transactions":[{"id":2633588,"accession":"0001491877-12-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001491877-12-000022","line_url":"/filing/0001491877-12-000022#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5167.0,"shares_display":"5,167","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":9817.3,"total_display":"9,817.30","total_whole":"9,817","shares_owned_after":105128.0,"shares_owned_after_display":"105,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-05","filed_date":"2012-04-09","scope":"insider"},{"id":8951179,"accession":"0001455244-11-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001455244-11-000025","line_url":"/filing/0001455244-11-000025","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12376.0,"shares_display":"12,376","price_per_share":5.507327957336781,"price_display":"5.51","price_state":"stated","total_value":68158.6908,"total_display":"68,158.69","total_whole":"68,159","shares_owned_after":115171.0,"shares_owned_after_display":"115,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-18","scope":"insider","n_lines":2},{"id":9038999,"accession":"0001455244-11-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001455244-11-000015","line_url":"/filing/0001455244-11-000015#line-2","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8596.0,"shares_display":"8,596","price_per_share":5.7561,"price_display":"5.76","price_state":"stated","total_value":49479.4356,"total_display":"49,479.44","total_whole":"49,479","shares_owned_after":122671.0,"shares_owned_after_display":"122,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-05","filed_date":"2011-04-05","scope":"insider"},{"id":8960068,"accession":"0001455244-11-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-11-000002","line_url":"/filing/0001455244-11-000002#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2985.0,"shares_display":"2,985","price_per_share":5.6513,"price_display":"5.65","price_state":"stated","total_value":16869.1305,"total_display":"16,869.13","total_whole":"16,869","shares_owned_after":95267.0,"shares_owned_after_display":"95,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-05","filed_date":"2011-01-07","scope":"insider"},{"id":7227500,"accession":"0001491877-10-000002","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001491877-10-000002","line_url":"/filing/0001491877-10-000002","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":5.712352666666667,"price_display":"5.71","price_state":"stated","total_value":85685.29,"total_display":"85,685.29","total_whole":"85,685","shares_owned_after":103555.0,"shares_owned_after_display":"103,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-17","filed_date":"2010-05-19","scope":"insider","n_lines":14},{"id":7653649,"accession":"0001455244-10-000093","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001455244-10-000093","line_url":"/filing/0001455244-10-000093","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5248.0,"shares_display":"5,248","price_per_share":5.341288109756097,"price_display":"5.34","price_state":"stated","total_value":28031.08,"total_display":"28,031.08","total_whole":"28,031","shares_owned_after":115852.0,"shares_owned_after_display":"115,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-05","filed_date":"2010-04-07","scope":"insider","n_lines":8},{"id":5634524,"accession":"0001455244-09-000133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-09-000133","line_url":"/filing/0001455244-09-000133#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":602.0,"shares_display":"602","price_per_share":5.0015,"price_display":"5.00","price_state":"stated","total_value":3010.903,"total_display":"3,010.90","total_whole":"3,011","shares_owned_after":82500.0,"shares_owned_after_display":"82,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-23","filed_date":"2009-11-25","scope":"insider"},{"id":5997225,"accession":"0001455244-09-000128","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001455244-09-000128","line_url":"/filing/0001455244-09-000128","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15638.0,"shares_display":"15,638","price_per_share":4.899039519120092,"price_display":"4.90","price_state":"stated","total_value":76611.18,"total_display":"76,611.18","total_whole":"76,611","shares_owned_after":88604.0,"shares_owned_after_display":"88,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-20","filed_date":"2009-11-23","scope":"insider","n_lines":4},{"id":5997214,"accession":"0001455244-09-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-09-000128","line_url":"/filing/0001455244-09-000128#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":12250.0,"total_display":"12,250.00","total_whole":"12,250","shares_owned_after":98740.0,"shares_owned_after_display":"98,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-19","filed_date":"2009-11-23","scope":"insider"},{"id":2928003,"accession":"0001396093-08-000010","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001396093-08-000010","line_url":"/filing/0001396093-08-000010","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001428524","owner_name":"Kessler Paul D.","owner_display_name":"Kessler Paul D.","owner_url":"/insider/0001428524","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark":"O","role_mark_label":"Officer (SVP Clinical, Med. & Reg.; CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical, Med. & Reg.; CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3120.0,"shares_display":"3,120","price_per_share":3.737301282051282,"price_display":"3.74","price_state":"stated","total_value":11660.38,"total_display":"11,660.38","total_whole":"11,660","shares_owned_after":42594.0,"shares_owned_after_display":"42,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-05","filed_date":"2008-03-07","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000072444","name":"NABI BIOPHARMACEUTICALS","url":"/issuer/0000072444","role":"Officer (SVP Clinical, Med. & Reg.; CMO)","n_filings":9,"first_seen":"2008-03-07","last_seen":"2012-04-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001428524","retrieved_at":"2026-08-22T19:37:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}